Endocrinology

 

The Endocrinology Network® Endocrinology clinical resource center is a central hub for all endocrine diseases featured on the site. Designed to offer clinicians the latest across multiple fields of endocrinology, this page hosts content related to diabetes, hormone therapy, women’s health, thyroid disorders, and much more. Check back for news on FDA approvals, the latest studies, conference coverage, case reports, and guideline updates.

Endocrine Case Report: Vomiting and Drunk

June 07, 2021

Our latest case report from Dr. Brady Pregerson features a man in his 30s presenting to the ED after drinking and admits to forgetting his insulin and poor adherence to other antidiabetes medication. Can you determine the correct diagnosis?

Baseline Risk Factors Contribute to Increased ASCVD Risk in Transgender Adolescents on Hormone Therapy

May 21, 2021

A retrospective review of ASCVD risk factors at baseline and 1 year after initiating hormone therapy among transgender adolescents suggests the increased risk of cardiovascular disease seen among this population could be driven by increased prevalence of baseline risk factors.

FDA Grants Clearance to Bigfoot Unity System, First "Smart" Pen Cap for Insulin Dosing

May 11, 2021

Bigfoot Medical announced the FDA granted 510(k) clearance to the Bigfoot Unity System for use in patients with type 1 or type 2 diabetes aged 12 years and older.

Any Fracture, Regardless of Location, Signals Increased Risk of Subsequent Fracture in Postmenopausal Women

May 05, 2021

A new study is challenging the notion that certain types of fractures, such as lower arm or wrist fractures, do not signal increased risk of subsequent fractures among postmenopausal women.

Endocrinology Case Report: Syncope and ST-Elevation

April 27, 2021

Our latest case report from Brady Pregerson, MD, features a middle-aged woman brought to the emergency department by paramedics as a field-activated ST-elevation MI. Check out the EKG and see if you can determine the correct diagnosis.

Endocrine Month in Review: April 2021

April 24, 2021

April's month in review features stories related to new diabetes medications, stem cells, disparities in care of women, and how exposure to endocrine-disrupting chemicals in pregnancy can impact mental health following delivery. Check back in during the last weekend of each month for the next Endocrine Month in Review.

Gender-Affirming Hormone Therapy Linked to Blood Pressure Changes in Transgender Individuals

April 20, 2021

The largest study of its kind is providing insight related to changes in blood pressure seen among transgender patients initiating gender-affirming hormone therapy.

FDA Makes Historic First Approving NEXTSTELLIS, an Oral Contraceptive Containing E4

April 20, 2021

The approval, which was awarded to Mayne Pharma, makes NEXTSTELLIS the first and only contraceptive pill containing E4, a natural occurring estrogen to receive approval from the FDA.

Exposure to Endocrine-Disrupting Chemicals Can Increase Risk of Postpartum Depression

April 02, 2021

An analysis of nearly 150 pregnant women presenting NY-based medical centers suggests prenatal exposure to endocrine-disrupting chemicals in plastics could increase odds of developing postpartum depression.

Daily Semaglutide Effective for Nonalcoholic Steatohepatitis in Phase 2 Trial

March 30, 2021

A phase 2 trial examining the effects of daily semaglutide over a 72-week period suggests the GLP1-RA could help patients with biopsy-confirmed nonalcoholic steatohepatitis (NASH) achieve NASH resolution.